SCHEMBL18671585

SCHEMBL18671585

Nc1ccn([C@@H]2O[C@H](CO)[C@H]3OC4(CCCC4)O[C@H]32)c(=O)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.60
MTOR P42345 2/20 0.60
THRB P10828 1/20 0.60
MDM2 Q00987 1/20 0.60
NCOA1 Q15788 1/20 0.60
NCOA3 Q9Y6Q9 1/20 0.60
PDE3A Q14432 3/20 0.51
PDE4D Q08499 1/20 0.51
SLC29A1 Q99808 1/20 0.51
CACNA1F O60840 2/20 0.47
ALB P02768 2/20 0.47
MAPT P10636 2/20 0.47
CACNA1D Q01668 2/20 0.47
CACNA1S Q13698 2/20 0.47
CACNA1C Q13936 2/20 0.47
NT5E P21589 1/20 0.41
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20668731 0.88 LMNA (0.63) LMNAMTORTHRBMDM2NCOA1
SCHEMBL13003005 0.88 LMNA (0.63) LMNAMTORTHRBMDM2NCOA1
SCHEMBL26320640 0.88 LMNA (0.63) LMNAMTORTHRBMDM2NCOA1
SCHEMBL9467302 0.88 LMNA (0.63) LMNAMTORTHRBMDM2NCOA1
SCHEMBL9755548 0.82 LMNA (0.72) LMNAMTORTHRBMDM2NCOA1
SCHEMBL18879926 0.81 LMNA (0.43) LMNAMTORTHRBMDM2NCOA1
SCHEMBL16647586 0.80 LMNA (0.45) LMNAMTORTHRBMDM2NCOA1
SCHEMBL16368423 0.78 SLC28A1 (0.58) SLC29A1
SCHEMBL18672072 0.78 SLC28A1 (0.58) SLC29A1
SCHEMBL11422515 0.77 LMNA (0.65) LMNAMTORTHRBMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3797782-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF FOR USE IN THE TREATMENT OF VIRAL INFECTIONS Janssen BioPharma, Inc. (US) 2021-03-31 EP disclosed
US-9603863-B2 Substituted nucleosides, nucleotides and analogs thereof ALIOS BIOPHARMA, INC. (US) 2017-03-28 US disclosed